Meiji Holdings Co., Ltd. (2269) Press Release
Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical’s Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ
Filed with TSE ·
6ix hasn’t read this filing yet.
Earlier from Meiji
- Notice concerning Completion of Payment in Full and Partial Forfeiture of Rights for Disposal of Treasury Stock under Restricted Stock Incentive Plan
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP]
- Notice concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation for Directors
- Notice Concerning Transfer of Shares of Subsidiaries Associated with Restructuring of Business Portfolio in China